NCT00004223 2023-06-18Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerEastern Cooperative Oncology GroupPhase 2 Completed
NCT02437370 2022-10-18Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial CancerUniversity of California, DavisPhase 1 Completed32 enrolled
NCT01282463 2019-09-09Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaEli Lilly and CompanyPhase 2 Completed148 enrolled 19 charts
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled